Humanized Chemically Defined Medium for Pluripotent Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating human embryonic stem cells (hESCs) into progenitor cells of the primary germ layers are limited by their specificity, reliance on undefined components like Foetal Bovine Serum and mouse feeders, and inability to achieve multi-lineage differentiation, which hampers their clinical applications and modeling of early mammalian development.
Innovation Solution
Human pluripotent cells are cultured in a fully humanized chemically defined medium supplemented with specific differentiation factors, allowing controlled differentiation into progenitor cells of the three primary germ layers, including ectoderm, mesoderm, and endoderm, without losing pluripotency, and are purified using techniques like FACS.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional differentiation methods are used, then specific primary germ layer progenitors can be generated, but the methods cannot achieve multi-lineage differentiation and are limited to single lineage
Solution Approach 1:
The differentiation process is divided into distinct temporal stages: early stage (days 0-3) withActivin A and FGF2 for primitive endoderm formation, middle stage (days 3-7) with BMP4 addition for mesoderm induction, and late stage (days 7-14) with Wnt3A for definitive endoderm specification. This segmented approach enables systematic multi-lineage differentiation while maintaining control over each germ layer's development
Solution Approach 2:
A single chemically defined medium formulation is designed to support differentiation into all three primary germ layers (ectoderm, mesoderm, endoderm) through sequential addition of differentiation factors. The medium universally supports multi-lineage differentiation without requiring lineage-specific medium changes, thereby achieving both versatility and reliability
2Productivity
If media containing Foetal Bovine Serum and mouse feeders are used, then cell growth is maintained, but clinical applications are limited due to undefined factors and animal-derived components
Solution Approach 1:
The culture medium composition is fundamentally changed from undefined serum-based formulations to a chemically defined medium with precisely controlled parameters. Specific concentrations of growth factors (Activin A: 10-50 ng/mL, FGF2: 10-50 ng/mL, BMP4: 10-50 ng/mL, Wnt3A: 10-50 ng/mL) are established to maintain cell growth and differentiation capacity without animal-derived components, thereby eliminating contaminants while preserving productivity
Solution Approach 2:
Recombinant human growth factors and cytokines serve as intermediaries to replace the undefined growth-promoting activities previously provided by Foetal Bovine Serum and mouse feeders. These defined mediators specifically activate signaling pathways (Activin/Nodal, FGF, BMP, Wnt) necessary for differentiation while being free from animal contaminants, thus enabling clinical application
3Stability of the object's composition
If undefined cellular matrix and serum are used, then pluripotent cell maintenance is achieved, but the potential for clinical applications and in vitro modeling is limited
Solution Approach 1:
The extracellular matrix composition is changed from undefined animal-derived matrices to defined human-derived alternatives with controlled physical and chemical parameters. Human fibronectin (5-20 μg/cm²) or laminin (5-20 μg/cm²) are used at specific concentrations to maintain cell adhesion and pluripotency while providing a clinically acceptable, contaminant-free substrate that enhances both stability and adaptability
Data Source
Figure 1
Figure 2
Figure 3
AI summary
This invention relates to the culture of pluripotent cells in a fully humanised chemically defined medium. Cells may be cultured over a prolonged period of time without losing their pluripotent status or may be controllably induced to differentiate into progenitor cells of the three primary germ layers by the addition of differentiation factors, for example differentiation factors which modulate one or more of the Activin/Nodal, FGF, Wnt or BMP signalling pathways.